(Date:7/3/2009)...reworks hazards , , FRIDAY, July 3 (Heal...use almost 10,000 injuries every year in the Unite...keep you and others safe while enjoying the key su...lth Inc. Corporation, which runs several Georgia-b...reworks safety: , Obey all local laws regarding ...
(Date:7/3/2009)...ewswire-Asia/ -- Sundia MediTech, a leading,integ...ng company in Shanghai,China announced today tha...esident of Chemistry Services. , Prior to j...iences, a drug,discovery and development company ...ntist to Senior Director of Medicinal Chemistry of...
(Date:7/3/2009)...ew urine drug test kit called DrugConfirm™ ,... that want a fast and accurate instant drug test. ...the cup has a sleek, innovative design and incorpo...very competitively priced compared to the other ur...the market , San Diego (V...
(Date:7/3/2009)...erseAges.com launches new content to include infor... and how to best deal with these health issues. ,...y 3, 2009 -- ReverseAges.com has recently launched...ngers of common health issues such as high blood p...y of factors, and the new content on ReverseAges.c...
Breaking Medicine News(10 mins):Health News:Put Safety First on the 4th 2Health News:Sundia MediTech Appoints Dr. Chen Chen as Senior VP of Chemistry 2Health News:New Urine Drug Test to Detect for 6 Major Drugs, Now Available at Drugstore.com -- 'DrugConfirm' Is a New Revolutionary Urine Drug Test 2Health News:New Urine Drug Test to Detect for 6 Major Drugs, Now Available at Drugstore.com -- 'DrugConfirm' Is a New Revolutionary Urine Drug Test 3...cent study shows that larger portions lead to grea...food, greater the amount that is eaten. Researcher...e differed depending on who determined the amount/...carried out with 50 men and women who were served ...
...glow that fireflies are famous for, are due to a g...lecule is now helping illuminate the effectiveness...new drugs for various diseases like AIDS,// Alzhei...carried out by researchers of the University of Mi...
...le and old age people are now increasingly taking ...rammes paint a rosy picture of beautiful gardens. ...health benefits, researchers now suggest that enth... no idea of how to lift properly and do not have a...
...foundation of diabetics care is the regular monito...any patients do not adhere to this routine because...multiple blood samples to be taken by puncturing//...rom University of Texas have discovered a new non-...
Other Medicine News:(Date:6/30/2009)...EGO, June 30 Calixa Therapeutics I...inical trial of CXA-101 in patients with complicat...ad-spectrum, parenteral cephalosporin antibiotic w...ainst Pseudomonas aeruginosa , including drug res...as a potential treatment for serious bacterial inf...
(Date:6/29/2009)...in major abdominal surgery patients achieved prima...lif., June 29 AcelRx Pharmaceutica... second Phase 2 clinical study evaluating the safe...TM) for the management of acute post-operative pai...spitalization. Compared to placebo, patients recei...
(Date:6/28/2009)... MAMEDE DO CORONADO, Portugal, June 29 /PRNewswire...ted that add-on treatment with the novel,once-da...etate; ESL) resulted,in a marked and sustained de... , Results from the one-year extension of a...were presented at the International Congress for E...
(Date:6/26/2009)... the news release, "Agendia,s Breast Cancer Recurr.... Gallen Expert Consensus Recommendations" issued,... Newswire, please be advised,that the subheadline...mitted,by PR Newswire. Complete, corrected releas...Agendia,s Breast Cancer Recurrence Test MammaPrint...
Breaking Medicine Technology:Calixa Therapeutics Announces Initiation of Phase 2 Clinical Trial of Its Antibiotic, CXA-101, in Patients with Complicated Urinary Tract Infections 2AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 2AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 3AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 4Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 2Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 3Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 4Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 5Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 6Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 7/C O R R E C T I O N -- Agendia B.V./ 2/C O R R E C T I O N -- Agendia B.V./ 3Proposed Assisted Living Regulations Would Allow Facilities to Rent Inaccessible Rooms to Persons Who Use Wheelchairs or Walkers 26428 1Proposed Assisted Living Regulations Would Allow Facilities to Rent Inaccessible Rooms to Persons Who Use Wheelchairs or Walkers 26428 2Proposed Assisted Living Regulations Would Allow Facilities to Rent Inaccessible Rooms to Persons Who Use Wheelchairs or Walkers 26428 3PA Governor Rendell Announces Nearly 24750 000 Investment in Nurse Education 26426 1PA Governor Rendell Announces Nearly 24750 000 Investment in Nurse Education 26426 2PA Governor Rendell Announces Nearly 24750 000 Investment in Nurse Education 26426 3PA Governor Rendell Announces Nearly 24750 000 Investment in Nurse Education 26426 4Epeius Biotechnologies Lead Product Rexin G for Metastatic Cancer Aptly Highlighted by National Cancer Institute Journal 7684 1Epeius Biotechnologies Lead Product Rexin G for Metastatic Cancer Aptly Highlighted by National Cancer Institute Journal 7684 2Enobia Pharma Presents PreClinical Data Showing ENB 0040 Significantly Improved Survival and Healed Skeletal Manifestations of Severe Hypophosphatasia 7682 1Enobia Pharma Presents PreClinical Data Showing ENB 0040 Significantly Improved Survival and Healed Skeletal Manifestations of Severe Hypophosphatasia 7682 2Enobia Pharma Presents PreClinical Data Showing ENB 0040 Significantly Improved Survival and Healed Skeletal Manifestations of Severe Hypophosphatasia 7682 3...ates 75% of patients receiving highest dose,achiev...une 25, 2007 /PRNewswire-FirstCall/ -- According t...Sessions of the,American Diabetes Association (ADA...ent liraglutide, a once- daily dose of human,GLP-1...treatment of,type 2 diabetes significantly improve...
... WIRE)--Jun 25, 2007 - Pfizer announced today,that...ced the risk,of stroke, coronary heart disease eve...atients who had no known coronary heart disease,bu...ke, compared,with placebo. The results are from a ...Aggressive Reduction in Cholesterol Levels,(SPARCL...
Other Medicine Technology:Phase II Results Show Once-Daily Dosing of Human GLP-1 Analog,Liraglutide, Brings Patients to A1c Target 2Phase II Results Show Once-Daily Dosing of Human GLP-1 Analog,Liraglutide, Brings Patients to A1c Target 3Phase II Results Show Once-Daily Dosing of Human GLP-1 Analog,Liraglutide, Brings Patients to A1c Target 4Lipitor Reduced the Risk of Coronary Events by Half and Stroke by,Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who,Experienced a Recent Stroke 2Lipitor Reduced the Risk of Coronary Events by Half and Stroke by,Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who,Experienced a Recent Stroke 3Cocoon Disposable Patient Warming Blankets are specially designed to prevent hypothermia and maintain normothermia in your patients. The soft warm coloured material is strong and resists tearing and
This blanket gently surrounds the child with temperature-controlled air. Use one or both of the enclosed clear plastic drapes to keep warmed air near the skin.
2-ply material consisting of polyethylene film inner layer and non-woven outer layers.
This unique blanket is designed to be used for many surgical procedures, including but not limited to: laminectomies, spinal procedures, abdominal procedures, and transplants.
Medicine Products: